|Synonyms||Lineage B.1.617; G/452.V3; “double mutation" variant; India variant|
|Description||SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Lineage B.1.617, also known as G/452.V3, was first identified in October 2020 in India. This variant has the double mutations E484Q and L452R in the spike proteins. Emerging research suggests the variant may be more transmissible than previously evolved ones. Whether the effectiveness of currently-deployed vaccines is affected remains under investigation. Moreover, the sublineages B.1.617.2 has been redesignated as "variant of concern" (VOC-21APR-02) in May 2021, which spreads more quickly than the original version of the virus.|
|Tag||C-terminal Avi &
protein is validated to bind with human ACE2 in functional ELISA assay.
|Molecular Weight||33.7 kDa as predicted
|Purity||>90% as analyzed
|Component||PBS 7.4, 0.5% PC300
|Storage||Upon receiving, the product can be stored for 6 months at -20°C or below. Please avoid repeated freeze-thaw cycles.|
|Note||For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.|
For more documents, please visit "Technical Support".